Literature DB >> 15833374

Immune responses to Campylobacter and serum autoantibodies in patients with complex regional pain syndrome.

Andreas Goebel1, Heiko Vogel, Onassis Caneris, Zahid Bajwa, Linda Clover, Norbert Roewer, Robert Schedel, Helge Karch, Guenter Sprotte, Angela Vincent.   

Abstract

We hypothesised that some complex regional pain syndromes (CRPS) may have a postinfectious and/or autoimmune basis. Sera from 92 patients with CRPS and 92 controls were investigated for immunoreactivity to Campylobacter strains and to rodent tissues. Both IgA-antibodies to Campylobacter and tissue-specific reactivity were often present in patients with short disease duration (< or = 1.5 years). Patients with minimal preceding trauma had stronger nervous tissue-specific reactivity than other patients, regardless of disease duration. These results provide preliminary evidence for immune activation early in CRPS and, additionally, that patients with minimal trauma may comprise an autoimmune subgroup.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833374     DOI: 10.1016/j.jneuroim.2005.01.018

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Current Concepts in Adult CRPS.

Authors:  Andreas Goebel
Journal:  Rev Pain       Date:  2011-06

Review 2.  Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.

Authors:  Marinos C Dalakas
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

3.  Cellular and behavioural models to predict responses to immunoglobulin G treatment in complex regional pain syndrome.

Authors:  A Goebel
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 4.  Immunoglobulin responsive chronic pain.

Authors:  Andreas Goebel
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

5.  7th International Immunoglobulin Conference: Interlaken Leadership Awards.

Authors:  M C Dalakas; W N Löscher
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 6.  New Concepts in Complex Regional Pain Syndrome.

Authors:  Maral Tajerian; John David Clark
Journal:  Hand Clin       Date:  2016-02       Impact factor: 1.907

7.  Pharmacological evaluation of tacrolimus (FK-506) on ischemia reperfusion induced vasculatic neuropathic pain in rats.

Authors:  Arunachalam Muthuraman; Shailja Sood
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2010-06-07

Review 8.  IVIg in other autoimmune neurological disorders: current status and future prospects.

Authors:  Marinos Dalakas
Journal:  J Neurol       Date:  2008-07       Impact factor: 4.849

9.  The prevalence of autoantibodies in complex regional pain syndrome type I.

Authors:  Maaike Dirckx; Marco W J Schreurs; Marissa de Mos; Dirk L Stronks; Frank J P M Huygen
Journal:  Mediators Inflamm       Date:  2015-02-08       Impact factor: 4.711

10.  Investigating Reports of Complex Regional Pain Syndrome: An Analysis of HPV-16/18-Adjuvanted Vaccine Post-Licensure Data.

Authors:  Frank Huygen; Kristin Verschueren; Candida McCabe; Jens-Ulrich Stegmann; Julia Zima; Olivia Mahaux; Lionel Van Holle; Maria-Genalin Angelo
Journal:  EBioMedicine       Date:  2015-07-06       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.